A passion for collaboration from the get-go: Merk and Co., Inc. and Bioxell show how big pharma and small biotechs can make perfect partners
Article Abstract:
Merck and Co., Inc. knows that collaborating with premium scientists is the best way to meet major medical needs and that is why they are reaching out to researchers all over the world. Italian biotech company BioXell is just one example of Merk's many partners showing how big and small biotech can make perfect partners.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2006
User Contributions:
Comment about this article or add new information about this topic:
Companies jostle for lead in RNAi, despite uncertainties
Article Abstract:
The commercial activities in the RNA interference (RNAi) space has continued despite the challenges related to interpretation of the technology, regulatory issues and intellectual property (IP) contests.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
What pharma wants
Article Abstract:
Six professionals from the pharmaceutical industry present their views about the new partnerships taking place between the pharmaceutical companies and biotechs for the development of new drugs.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2007
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Investment and financing constraints: evidence from the funding of corporate pension plans. The foundations of freezeout laws in takeovers
- Abstracts: Default risk in equity returns. How to discount cashflows with time-varying expected returns. The cross-section of volatility and expected returns
- Abstracts: Testing the law of one price in the Chinese wholesale food markets. Do psychological prices contribute to price rigidity? Evidence from German scanner data on food brands
- Abstracts: Eurobond underwriter spreads. R&D, knowledge spillovers and stock volatility. Signalling power of special dividends in an imputation environment
- Abstracts: Financial factors in R&D budget setting: the impact of interfunctional market coordination, strategic alliances, and the nature of competition